Regulatory Services in Thailand
Thailand's pharmaceutical market will continue on a positive growth trajectory. Efforts are being made to reform regulatory processes for innovative drug registrations helping Thailand to attract greater foreign investment into its domestic pharmaceutical industry. However, comparatively the low levels of affordability and poor access to healthcare, the market is highly suited to generic producers.
Market size in 2019 was $ 5.9bn experiencing a growth of 8.17. It is expected to grow at 8.7% in 2020 and reach $ 6.43 bn.
Thailand has attracted almost all major global pharmaceutical companies.